- Volume is elevated versus the 13-week average, confirming attention.
RTO
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Rentokil Initial plc · Industrials · Specialty Business Services
Latest close
360.1 GBP
4.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -21.0% below the Trend Line and sits at 17.2% of its 52-week range. The latest completed week returned 4.4%, after a -18.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 49/100.
Setup score
36
out of 100
Latest Close
360.1 GBP
7 Aug 2026
1W Return
4.4%
latest completed week
4W Return
-18.2%
short-term follow-through
12W Return
-23.8%
quarterly tape
Trend Breadth
73.1%
38 of 52 weeks active
Volume Ratio
2.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.4%
Latest completed week; four-week move -18.2%.
Indicator stack
40/31
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
49/100
30 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -21.0% below the Trend Line and sits at 17.2% of its 52-week range. The latest completed week returned 4.4%, after a -18.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1512-week average 0.53
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -18.2% over four weeks, -23.8% over 12 weeks, and -4.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year38
Trend breadth73.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.14Latest activity-pressure read.
Pressure change18.7%Four-week change in activity pressure.
Leadership-23.48Latest relative-leadership reading.
RS change-562.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength24/100Blend of value, momentum, and quality. Underlying universe rank 77; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum16/100Medium-term price momentum. Underlying universe rank 85; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework43/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 19.3x Price divided by trailing earnings.
- Price / sales
- 1.3x Market value relative to trailing revenue.
- EV / EBITDA
- 10.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 5.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 83.1% Gross profit retained from each unit of revenue.
- Operating margin
- 9.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 10.2% Free cash flow generated from revenue.
- Return on invested capital
- 5.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.4% Latest one-year revenue growth.
- EPS growth
- 19.8% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 18.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 2.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment49/100
Weighted news tone is neutral across 30 relevant articles.
4 positive · 24 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.0%Distance below the 52-week high.
13-week volatility5.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+6.7%Week of 3 Apr.
Worst week-19.1%Week of 31 Jul.
Latest week+4.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks0
Modest losses11
Sharp losses4
Recent vol5.7%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Industrials
4-week rank100 / 100
Group average9.1%
Trend breadth46.0%
Trend46.0%active weekly trend signals
MD65.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryGB Specialty Business Services
4-week rank20 / 21
Group average1.6%
Trend breadth38.1%
Trend38.1%active weekly trend signals
MD61.9%positive activity pressure
RS28.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape40/100
Trend, activity pressure, participation, and risk combine to a 40/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 2/12.
Activity pressure 0.15; No reversal markers Factors35/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 80 SVQF43/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 149.0 of 260 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment49/100Weighted news tone is neutral across 30 relevant articles.
Rentokil Initial PLC (RTO) Shares Fall 17.6% -- What GF Score of 83 Tells Investors Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 360.1 GBP | 4.4% | 455.5 GBP | 426.6 GBP | -1.14 | -23.48 | 99.5M | Off |
| 31 Jul 2026 | 344.8 GBP | -19.1% | 459.2 GBP | 428.2 GBP | -1.12 | -26.78 | 118.0M | Off |
| 24 Jul 2026 | 426.0 GBP | -5.3% | 462.5 GBP | 429.9 GBP | -1.18 | -8.76 | 41.1M | Off |
| 17 Jul 2026 | 450.0 GBP | 2.3% | 463.1 GBP | 431.2 GBP | -1.30 | -2.43 | 16.6M | Off |
| 10 Jul 2026 | 440.0 GBP | -1.1% | 462.9 GBP | 432.4 GBP | -1.40 | -3.54 | 37.9M | Off |
| 3 Jul 2026 | 445.1 GBP | 2.5% | 462.5 GBP | 433.5 GBP | -1.51 | -3.93 | 2.1M | Off |
| 26 Jun 2026 | 434.3 GBP | 1.2% | 461.8 GBP | 434.5 GBP | -1.55 | -4.66 | 3.5M | Off |
| 19 Jun 2026 | 429.0 GBP | -5.4% | 461.2 GBP | 435.6 GBP | -1.47 | -4.48 | 14.5M | Off |
| 12 Jun 2026 | 453.6 GBP | 2.5% | 460.4 GBP | 436.9 GBP | -1.28 | 0.02 | 6.6M | Off |
| 5 Jun 2026 | 442.4 GBP | -1.4% | 458.7 GBP | 438.1 GBP | -1.11 | -1.30 | 7.8M | Off |
| 29 May 2026 | 448.8 GBP | -3.3% | 457.7 GBP | 439.3 GBP | -0.72 | -0.14 | 46.9M | On |
| 22 May 2026 | 463.9 GBP | -1.8% | 456.8 GBP | 440.6 GBP | -0.41 | 2.80 | 50.8M | On |
| 15 May 2026 | 472.5 GBP | -2.5% | 456.0 GBP | 441.7 GBP | -0.16 | 7.67 | 41.6M | On |
| 8 May 2026 | 484.7 GBP | -2.4% | 453.6 GBP | 442.8 GBP | 0.08 | 10.33 | 30.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.